Organon (OGN) Payables (2020 - 2026)

Organon has reported Payables for 7 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Payables fell 1.5% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 1.5% decrease from a year earlier, with the FY2025 full-year figure at $952.0 million, down 18.35% from the prior year.
• Payables was $1.1 billion for Q2 2026 at Organon, up from $983.0 million in the prior quarter.
• The five-year high for Payables was $1.3 billion in Q4 2023, with the low at $952.0 million in Q4 2025.
• Average Payables over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Payables sank 39.41% in 2022, then climbed 17.49% in 2023.
• Over 5 years, Payables stood at $1.1 billion in 2022, then gained by 17.49% to $1.3 billion in 2023, then retreated by 12.33% to $1.2 billion in 2024, then fell by 18.35% to $952.0 million in 2025, then advanced by 10.4% to $1.1 billion in 2026.
• The last three Payables figures came in at $1.1 billion (Q2 2026), $983.0 million (Q1 2026), and $952.0 million (Q4 2025), per Business Quant data.